Discovery of an acyclic nucleoside phosphonate that inhibits Mycobacterium Tuberculosis ThyX based on the binding mode of a 5-alkynyl substrate analogue
Anastasia Parchina, Matheus Froeyen, Lia Margamuljana, Jef Rozenski, Steven De Jonghe, Yves Briers, Rob Lavigne, Piet A. Herdewijn, Eveline Lescrinier · container not stated · 2014
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
· OpenAlex · conference-paper · 2014
Abstract
The urgent need for new antibiotics poses a challenge to target un(der)exploited vital cellular processes.Thymidylate biosynthesis is one of these processes due to its crucial role in DNA replication and repair.Thymidylate synthases (TS) catalyze a crucial step in the biosynthesis of TTP, an elementary building block required for DNA synthesis and repair.To date, TS inhibitors are only successfully applied in anticancer therapy due to their lack of specificity for antimicrobial versus human enzymes.However the discovery of a new family of TS enzymes (ThyX) in a range of pathogenic bacteria that is structurally and biochemically different from the 'classic' TS (ThyA) opened possibilities to develop selective ThyX inhibitors as potent antimicrobial drugs.In this work we explored the interaction of the known inhibitor (compound 1) with M. tuberculosis ThyX enzyme using molecular modeling and confirmed our findings with NMR experiments.While the dUMP moiety of compound 1 occupies the cavity of the natural substrate in ThyX, the rest of the ligand (the '5-alkynyl tail') extends to the outside of the enzyme between two of its four subunits.The hydrophobic pocket that accommodates the alkyl part of the 'tail' is formed by displacement of Tyr44.C, Tyr108.A and Lys165.A.
Changes of Lys165-NH3 upon ligand binding were monitored in a titration experiment by 2D NMR HISQC.Inspired by the success of acyclic antiviral nucleosides, we have synthesized compounds where 5-alkynyl uracyl was coupled to acyclic nucleoside phosphonates (ANPs).One of these compounds showed 43% of inhibitory effect on ThyX at 50µM.
Open the resolved locator · 10.1135/css201414342
Metadata licence: OpenAlex metadata (CC0)